Jazz Pharmaceuticals
JAZZ
JAZZ
545 hedge funds and large institutions have $7.44B invested in Jazz Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 100 funds opening new positions, 218 increasing their positions, 153 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
545
Holders Change
+40
Holders Change %
+7.92%
% of All Funds
7.4%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
100
Increased
218
Reduced
153
Closed
52
Calls
$66.4M
Puts
$24.7M
Net Calls
+$41.6M
Net Calls Change
+$32M
Top Buyers
| 1 |
Holocene Advisors
New York
|
+$61.1M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$49.9M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$48.6M |
| 4 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
+$44.4M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$36.4M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$170M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$142M |
| 3 |
VPC
Vestal Point Capital
New York
|
-$120M |
| 4 |
Millennium Management
New York
|
-$73.2M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$59.7M |
